Sutro Biopharma STRO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 24.91 | 102.15 | -2.94 | -29,614 | -38 | |
| 2025Q4 | 11.57 | 102.02 | -5.39 | -38,049 | -47 | |
| 2025Q3 | 8.68 | 102.7 | -6.7 | -48,459 | -57 | |
| 2025Q2 | 7.14 | 178.88 | -1.32 | -3,345 | -11 | |
| 2025Q1 | 6.51 | 102.84 | -9.08 | -68,514 | -76 | |
| 2024Q4 | 18.4 | 106.29 | -8.7 | -65,258 | -72 | |
| 2024Q3 | 34.6 | 209.69 | -5.8 | -67,919 | -49 | |
| 2024Q2 | 29.3 | 106.92 | -5.4 | -48,685 | -48 | |
| 2024Q1 | 56.5 | 103.44 | -9.5 | -56,591 | -58 | |
| 2023Q4 | 42.9 | 95.53 | 5.2 | 43,152 | 31 | |
| 2023Q3 | 34.7 | 104.29 | -8.1 | -44,014 | -49 | |
| 2023Q2 | 46.5 | 99.84 | -6.4 | -46,179 | -39 | |
| 2023Q1 | 46.2 | 106.45 | -8.5 | -42,237 | -50 | |
| 2022Q4 | 80.8 | 106.08 | -6.1 | -49,222 | -35 | |
| 2022Q3 | 55.5 | 111.96 | -3.5 | -21,210 | -19 | |
| 2022Q2 | 52.1 | 101.03 | -5.5 | -19,379 | -26 | |
| 2022Q1 | 82.2 | 100.3 | -8.4 | -39,132 | -39 | |
| 2021Q4 | 148.8 | 100.27 | -8.3 | -35,036 | -38 | |
| 2021Q3 | 188.9 | 100.32 | -6.7 | -34,674 | -31 | |
| 2021Q2 | 185.9 | 101.82 | -1.3 | -9,805 | -6 |